Sun Pharma reports net profit of Rs 1064 crore in Q2

Total revenue from operations during the period under review stood at Rs 8,123.35 crore as against Rs 6,937.63 crore in the year-ago quarter, said Sun Pharma.

New Delhi: Shares of Sun Pharmaceutical Industries on Thursday went up by over 3 per cent after the company reported a consolidated net profit at Rs 1,064.09 crore in the second quarter ended September 30. The company's scrip climbed 3.02 per cent to close at Rs 440.45 on the BSE. During the trade, it jumped 3.84 per cent to Rs 444.

It was the top gainer among the 30-Sensex components. On the NSE, it gained 3.41 per cent to close at Rs 442.50.

In terms of the traded volume, 8.96 lakh shares of the company were traded on the BSE and over one crore shares on the NSE during the day.

Read Also: Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

The company had posted a consolidated net loss of Rs 269.6 crore in the same period last fiscal, Sun Pharma said in a regulatory filing.

Total revenue from operations during the period under review stood at Rs 8,123.35 crore as against Rs 6,937.63 crore in the year-ago quarter, it added.

Sun Pharma said its active pharmaceutical ingredients (API) clocked external sales of Rs 468 crore, up 10 per cent over the same quarter last fiscal.

Read Also: Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr